President imageMessage from President & CEO of Nobelpharma America, LLC

Yoshiki Kida, President & CEO of Nobelpharma America, LLC

 Contributing to society by providing novel pharmaceuticals and medical devices for the high unmet medical needs”

 Nobelpharma America’s overall Mission Statement, follows the Mission of our parent company, Nobelpharma Co., Ltd.

 Nobelpharma America focuses heavily on patients awaiting novel treatments for their specific disease state. While sales and profitability are important indicators of corporate success, we gauge success by adherence to our corporate Mission Statement, allowing novel life-changing treatments to be brought to market.

Our corporate Action Criteria states, “When in doubt, the patient’s benefit takes priority,” which supports our approach to overcoming challenges throughout the product development process.

You never know unless you try, but do not hesitate to cut loss

 “If there is no precedence, be the first to try

Nobelpharma America, LLC is a wholly owned subsidiary of Nobelpharma Co., Ltd., Tokyo, Japan.  We are proud to bring unique, life-changing medications from Nobelpharma Co., Ltd. to best serve US patients, caregivers and health care providers.

 

                                                                                                                                                                                            Yoshiki Kida

Bethesda Office Center